Upgrade to SI Premium - Free Trial

Streamline Health® Reports Fourth Quarter And Fiscal Year 2015 Financial Performance

April 20, 2016 5:01 PM

ATLANTA, April 20, 2016 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the Looking Glass® platform of integrated solutions and analytics supporting revenue cycle optimization for healthcare enterprises in the new value-based world, today announced financial results for the fourth quarter and fiscal year of 2015, which ended January 31, 2016.

Revenue for the three-month period ended January 31, 2016 declined 3.4 percent to $6.4 million as compared to the three-months ending January 31, 2015. Adjusted EBITDA for the fourth quarter was $0.5 million, up from $(0.7) million in the same period a year ago. Net loss for the fourth quarter was $1.8 million, improved from a $5.1 million net loss in the same period a year ago.

Revenues for fiscal year 2015 were $28.3 million, up 2.5% from $27.6 million the previous fiscal year. Recurring revenues for the year constituted 85% of overall revenue, or $24.1 million. Adjusted EBITDA for the fiscal year was $2.8 million, up from ($1.0) million in fiscal year 2014.

"2015 was a year of significant improvement over 2014 in terms of our balance sheet and operational efficiency," stated David Sides, President and Chief Executive Officer, Streamline Health. "Cash from operations improved year over year by nearly $9 million from ($3.0) million to $5.9 million. We increased our total cash on hand by $3.4 million and reduced our term loans by $1.5 million. In addition, we improved Adjusted EBITDA by $3.8 million year over year.

We have begun investing significantly in sales and marketing to ramp up our revenue growth going forward and are rebalancing our solution development efforts from a stability emphasis to one focused on innovation that addresses our future client needs and drives higher quality for our users as our industry moves to value-based care."

Highlights for the fourth quarter and fiscal year ended January 31, 2016 included:

  • Revenues for the fourth quarter 2015 were $6.4 million, and for the year were $28.3 million;
  • Adjusted EBITDA for the fourth quarter 2015 was $0.5 million, and for the year was $2.8 million;
  • Recorded net loss of $(1.4) million for the three-month period ended January 31, 2016, and $(4.3) million for the fiscal year 2015;
  • New sales bookings for the quarter were $2.0 million and $15.3 million for the fiscal year; and
  • Backlog at the end of the quarter was $67.1 million.

Conference Call Information

The Company will conduct a conference call to review the results on Wednesday, April 20, 2016 at 5:00 PM ET. Interested parties can access the call via live webcast; click here to register. The call can also be accessed by dialing 888-359-3624 and then entering passcode 2145327.

A replay of the conference call will be available from Wednesday, April 20, 2016 at 8:00 PM ET to Monday, April 25, 2016 at 8:00 PM ET by dialing 888-203-1112 and entering passcode 2145327.

*Non-GAAP Financial Measures

Streamline Health reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that this measure provides useful supplemental information regarding the performance of Streamline Health's business operations.

Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees. A table illustrating this measure is included in this press release.

About Streamline HealthStreamline Health Solutions, Inc. (NASDAQ: STRM) is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge­ – actionable insights that support revenue cycle optimization for healthcare enterprises. Our Looking Glass® platform delivers integrated solutions and analytics that enable providers to drive reimbursement in a value-based world. We share a common calling and commitment to advance the quality of life and the quality of healthcare – for society, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's estimates of future revenue, backlog, results of investments in sales and marketing, success of future products and related expectations and assumptions. These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development and enhancement of current solutions, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Company Contact:Randy SalisburySVP, Chief Marketing Officer(404) 229-4242[email protected]

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months Ended

January 31,

Fiscal Year Ended

2016

2015

2016

2015

Revenues:

Systems sales

$

378,594

$

215,670

$

2,946,304

$

1,214,879

Professional services

580,124

848,279

2,212,002

2,580,167

Maintenance and support

3,829,816

3,745,952

15,145,480

16,157,371

Software as a service

1,582,314

1,785,622

8,010,672

7,672,990

Total revenues

6,370,848

6,595,523

28,314,458

27,625,407

Operating expenses:

Cost of systems sales

660,632

1,031,305

2,778,041

3,536,495

Cost of services

894,852

1,012,518

3,143,881

3,458,984

Cost of maintenance and support

738,778

534,662

3,036,550

3,087,842

Cost of software as a service

389,385

807,013

2,442,143

2,920,403

Selling, general and administrative

2,806,429

3,299,977

13,442,799

16,225,574

Research and development

2,377,712

2,905,233

9,093,353

9,756,206

Impairment of intangible assets

--

1,952,000

--

1,952,000

Total operating expenses

7,867,788

11,542,708

33,936,767

40,937,504

Operating loss

(1,496,940)

(4,947,185)

(5,622,309)

(13,312,097)

Other income (expense):

Interest expense

(185,824)

(225,370)

(884,226)

(748,969)

Loss on early extinguishment of debt

--

(315,327)

--

(429,849)

Miscellaneous income (expenses)

284,880

(211,060)

2,224,423

1,592,449

Loss before income taxes

(1,397,884)

(5,698,942)

(4,282,112)

(12,898,466)

Income tax (expense) benefit

(5,358)

889,299

(8,003)

887,009

Net loss

$

(1,403,242)

$

(4,809,643)

$

(4,290,115)

$

(12,011,457)

Less: deemed dividends on Series A Preferred Shares

(369,058)

(286,809)

(1,336,072)

(1,038,310)

Net loss attributable to common shareholders

$

(1,772,300)

$

(5,096,452)

$

(5,626,187)

$

(13,049,767)

Basic net loss per common share

$

(0.09)

$

(0.28)

$

(0.30)

$

(0.71)

Number of shares used in basic per common share computation

18,689,854

18,417,100

18,689,854

18,261,800

Diluted net loss per common share

$

(0.09)

$

(0.28)

$

(0.30)

$

(0.71)

Number of shares used in diluted per common share computation

18,689,854

18,417,100

18,689,854

18,261,800

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

Assets

January 31,

2016

2015

Current assets:

Cash and cash equivalents

$

9,882,136

$

6,522,600

Accounts receivable, net of allowance for doubtful accounts of $155,407 and $665,962, respectively

4,199,315

6,935,270

Contract receivables

119,697

191,465

Prepaid hardware and third party software for future delivery

5,858

55,173

Prepaid client maintenance contracts

956,913

935,858

Other prepaid assets

941,532

1,437,680

Deferred income taxes

--

220,004

Other current assets

97,986

207,673

Total current assets

16,203,437

16,505,723

Non-current assets:

Property and equipment:

Computer equipment

2,647,135

2,381,923

Computer software

801,895

964,857

Office furniture, fixtures and equipment

683,443

683,443

Leasehold improvements

729,348

724,015

4,861,821

4,754,238

Accumulated depreciation and amortization

(2,407,746)

(1,617,423)

Property and equipment, net

2,454,075

3,136,815

Contract receivables, less current portion

8,711

43,553

Capitalized software development costs, net of accumulated amortization of $14,919,948 and $11,846,468 respectively

6,123,638

9,197,118

Intangible assets, net of accumulated amortization of $84,531 and $13,677, respectively

8,155,325

9,500,317

Deferred financing costs

270,147

387,199

Goodwill

16,184,667

16,184,667

Other

746,018

823,723

Total non-current assets

33,942,581

39,273,392

$

50,146,018

$

55,779,115

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

Liabilities and Stockholders' Equity

January 31,

2016

2015

Current liabilities:

Accounts payable

$

1,136,779

$

2,298,851

Accrued compensation

935,324

865,865

Accrued other expenses

328,551

563,838

Current portion of long-term debt

673,807

500,000

Deferred revenues

10,447,280

9,289,076

Current portion of capital lease obligation

592,642

781,961

Total current liabilities

14,114,383

14,299,591

Non-current liabilities:

Term loans

7,861,084

9,500,000

Warrants liability

205,113

1,834,380

Royalty liability

2,291,888

2,385,826

Lease incentive liability, less current portion

369,406

342,129

Capital lease obligation

93,257

582,911

Deferred revenues, less current portion

1,212,709

964,933

Deferred income tax liability, less current portion

--

229,579

Total non-current liabilities

12,033,457

15,839,758

Total liabilities

26,147,840

30,139,349

Series A 0% Convertible Redeemable Preferred stock, $.01 parvalue per share, $8,849,985 redemption value, 4,000,000 sharesauthorized, 2,949,995 issued and outstanding, net of unamortizedpreferred stock discount of $875,935 and $2,212,007, respectively

7,974,050

6,637,978

Stockholders' equity:

Common stock, $.01 par value per share, 45,000,000 shares authorized, 18,783,540 and 18,553,389 shares issued and outstanding, respectively

187,836

185,534

Additional paid in capital

79,700,577

78,390,424

Accumulated deficit

(63,864,285)

(59,574,170)

Total stockholders' equity

16,024,128

19,001,788

$

50,146,018

$

55,779,115

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Fiscal Year

2015

2014

Operating activities:

Net loss

$

(4,290,115)

$

(12,011,457)

Adjustments to reconcile net loss to net cash provided by (used in)

operating activities:

Depreciation

1,245,400

1,005,283

Amortization of capitalized software development costs

3,073,479

3,677,991

Amortization of intangible assets

1,344,992

1,396,317

Amortization of other deferred costs

206,881

189,107

Amortization of debt discounts

--

47,552

Valuation adjustment for warrants liability

(1,629,267)

(2,283,345)

Deferred tax expense (benefit)

(9,575)

(720,582)

Other valuation adjustments

(39,299)

128,855

Gain from early extinguishment of lease liability

(33,059)

--

Loss on impairment of intangible assets

--

1,952,000

Loss from early extinguishment of debt

--

315,327

Loss on disposal of fixed assets

92,448

180,793

Loss on exit of operating lease

--

234,823

Share-based compensation expense

2,386,490

1,934,298

Provision for accounts receivable

124,235

440,771

Changes in assets and liabilities, net of assets acquired:

Accounts and contract receivables

2,718,330

2,157,977

Other assets

575,774

(637,348)

Accounts payable

(1,117,986)

600,263

Accrued expenses

(174,133)

(1,422,571)

Deferred revenues

1,405,980

(197,698)

Net cash provided by (used in) operating activities

5,880,575

(3,011,644)

Investing activities:

Purchases of property and equipment

(518,254

(2,125,240)

Capitalization of software development costs

--

(619,752)

Payment for acquisition, net of cash acquired

--

(6,058,225)

Net cash used in investing activities

(518,254)

(8,803,217)

Financing activities:

Proceeds from term loan

--

10,000,000

Principal repayments on term loan

(1,465,109)

(8,297,620)

Principal repayments on note payable

--

(900,000)

Principal payments on capital lease obligation

(815,826)

(368,386)

Payment of deferred financing costs

2,111

(573,002)

Proceeds from exercise of stock options and stock purchase plan

276,039

551,583

Net cash provided by (used in) financing activities

(2,002,785)

412,575

Increase (decrease) in cash and cash equivalents

3,359,536

(11,402,286)

Cash and cash equivalents at beginning of year

6,522,600

17,924,886

Cash and cash equivalents at end of year

$

9,882,136

$

6,522,600

STREAMLINE HEALTH SOLUTIONS, INC.

Backlog

(Unaudited)

Table A

January 31, 2016

October 31, 2015

January 31, 2015

Streamline Health Software Licenses

$

21,586,000

$

21,533,000

$

20,888,000

Hardware and Third Party Software

200,000

200,000

244,000

Professional Services

5,803,000

5,951,000

7,485,000

Maintenance and Support

23,292,000

21,057,000

21,304,000

Software as a Service

16,264,000

18,738,000

22,574,000

Total

$

67,145,000

$

67,479,000

$

72,495,000

STREAMLINE HEALTH SOLUTIONS, INC.

New Bookings

(Unaudited)

Table B

Fiscal Year Ended

January 31, 2016

Value

% ofTotalBookings

Streamline Health Software licenses

$

7,153,000

47%

Software as a service

2,519,000

16%

Maintenance and support

1,318,000

9%

Professional services

4,262,000

28%

Hardware & third party software

41,000

0%

Total bookings

$

15,293,000

100%

Reconciliation of Non-GAAP Financial Measures(Unaudited)Table C

This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Streamline Health's management in its operating and financial decision-making uses non-GAAP financial measures because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the Company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions.

Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands):

Adjusted EBITDA Reconciliation

Three Months Ended,

Twelve Months Ended,

January 31, 2016

January 31, 2015

January 31, 2016

January 31, 2015

Net loss

$

(1,403)

$

(4,809)

$

(4,290)

$

(12,011)

Interest expense

186

225

884

749

Income tax benefit

5

(889)

8

(887)

Depreciation

314

334

1,245

1,005

Amortization of capitalized software development costs

741

942

3,073

3,678

Amortization of intangible assets

333

345

1,345

1,396

Amortization of other costs

46

45

136

166

EBITDA

222

(3,807)

2,402

(5,904)

Share-based compensation expense

527

648

2,386

1,934

Loss on impairment of intangibles

--

1,952

--

1,952

Loss on early extinguishment of debt

--

315

--

430

Loss on disposal of fixed assets

--

70

92

181

Non-cash valuation adjustments to assets and liabilities

(317)

52

(1,669)

(2,154)

Transaction related professional fees, advisory fees and

other internal direct costs

40

6

93

182

Associate severances and other costs relating to

transactions or corporate restructuring

--

70

206

901

Other non-recurring operating expenses

--

--

(750)

1,491

Adjusted EBITDA

$

472

$

(694)

$

2,761

$

(987)

Adjusted EBITDA per diluted share

Loss per share – diluted

$

(0.09)

$

(0.28)

$

(0.30)

$

(0.71)

Adjusted EBITDA per adjusted diluted share (1)

$

0.03

$

(0.04)

$

0.15

$

(0.05)

Diluted weighted average shares

18,689,854

18,417,100

18,689,854

18,261,800

Includable incremental shares — adjusted EBITDA (2)

--

--

--

--

Adjusted diluted shares

18,689,854

18,417,100

18,689,854

18,261,800

(1)

Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method.

(2)

The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed.

Logo - http://photos.prnewswire.com/prnh/20151208/294363LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/streamline-health-reports-fourth-quarter-and-fiscal-year-2015-financial-performance-300254964.html

SOURCE Streamline Health Solutions, Inc.

Categories

Press Releases

Next Articles